This study was designed to compare the mean percent change of LDL-C between Lipilou® 10mg and 20mg group after 12 weeks of treatment.

Inclusion Criteria:

• Patients who had hypercholesterolemia with high risk, according to the 2015 Korean guidelines for managing dyslipidemia.

Exclusion Criteria:

• Patients with uncontrolled diabetes mellitus, uncontrolled hypertension, thyroid dysfunction.
• Patients who are legally unable to participate in clinical trials or who are unable to participate in clinical trials based on investigator's decision.